Artiva Biotherapeutics (ARTV) Earnings Date, Estimates & Call Transcripts $1.92 -0.05 (-2.54%) Closing price 04:00 PM EasternExtended Trading$1.97 +0.05 (+2.60%) As of 05:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Artiva Biotherapeutics Earnings Summary Artiva Biotherapeutics released Q1 2025 earnings on May 8, 2025, reporting an EPS of -$0.83, which missed the consensus estimate of -$0.68 by $0.15. With a trailing EPS of $0.00, Artiva Biotherapeutics' earnings are expected to grow next year, from ($4.95) to ($2.83) per share. Upcoming Q2 Earnings DateJun. 23Before Market OpensEstimatedConsensus EPS (May. 8) -$0.68 Actual EPS (May. 8) -$0.83 Missed By -$0.15 Q1 2025 Earnings ResourcesQ1 2025 Earnings Report Press Release (8-K) Quarterly Report (10-Q)ARTV Upcoming EarningsArtiva Biotherapeutics' next earnings date is estimated for Monday, June 23, 2025, based on past reporting schedules. Powered by Get Artiva Biotherapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Artiva Biotherapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataARTV Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Artiva Biotherapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.68-$0.62-$0.65Q2 20252-$0.70-$0.66-$0.68Q3 20252-$0.73-$0.70-$0.72Q4 20252-$0.77-$0.57-$0.67 FY 2025 8 -$2.88 -$2.55 -$2.72 Q1 20261-$0.73-$0.73-$0.73Q2 20261-$0.76-$0.76-$0.76Q3 20261-$0.78-$0.78-$0.78Q4 20261-$0.81-$0.81-$0.81 Artiva Biotherapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 6/23/2025(Estimated)--------5/8/2025--$0.68-$0.83 -$0.15-$0.83--11/12/2024--$0.68-$0.92 -$0.24-$0.92$0.30M-8/29/2024Q2 2024-$1.07-$19.10 -$18.03-$16.20-- Artiva Biotherapeutics Earnings - Frequently Asked Questions When is Artiva Biotherapeutics's earnings date? Artiva Biotherapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, June 23rd, 2025 based off last year's report dates. Learn more on ARTV's earnings history. Did Artiva Biotherapeutics beat their earnings estimates last quarter? In the previous quarter, Artiva Biotherapeutics (NASDAQ:ARTV) missed the analysts' consensus estimate of ($0.68) by $0.15 with a reported earnings per share (EPS) of ($0.83). Learn more on analysts' earnings estimate vs. ARTV's actual earnings. How much revenue does Artiva Biotherapeutics generate each year? Artiva Biotherapeutics (NASDAQ:ARTV) has a recorded annual revenue of $251,000.00. What is Artiva Biotherapeutics's EPS forecast for next year? Artiva Biotherapeutics's earnings are expected to grow from ($4.95) per share to ($2.83) per share in the next year. More Earnings Resources from MarketBeat Related Companies Kodiak Sciences Earnings Date Tonix Pharmaceuticals Earnings Date Cardiff Oncology Earnings Date SOPHiA GENETICS Earnings Date Voyager Therapeutics Earnings Date Y-mAbs Therapeutics Earnings Date CARGO Therapeutics Earnings Date scPharmaceuticals Earnings Date DiaMedica Therapeutics Earnings Date Eledon Pharmaceuticals Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsAdvance Auto Parts: Did Earnings Defuse Tariff Concerns?Booz Allen Hamilton Earnings: 3 Bullish Signals for BAH StockAdvance Auto Parts Jumps on Surprise Earnings BeatAlibaba's Earnings Just Changed Everything for the StockCisco Stock Eyes New Highs in 2025 on AI, Earnings, UpgradesSymbotic Gets Big Earnings Lift: Is the Stock Investable Again? This page (NASDAQ:ARTV) was last updated on 5/28/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe biggest threat isn’t ChinaWhile the headlines focus on AI models and chip speed, Elon Musk is investing in the material side of the stor...True Market Insiders | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe trade war twist nobody saw comingThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Artiva Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Artiva Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.